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Introduction: The positioning of implants in the jaw bones with contextual graftless lateral approach sinus lifting is
finding an increasingly broad consensus in the literature.
Since the 1970s, various clinical research projects have been conducted on applications of biological and synthetic
biomaterials in bone regenerative surgery, both in sinus lift procedures and in cystic cavity filling after cystectomy
or in bone defects in regenerative periodontal surgery. Currently, we are finding that there is an increasing trend of
clinicians aiming to adopt graftless techniques, with satisfactory results in terms of implant survival in the long term.
In our study, through a case report, we describe a variant of graftless sinus augmentation technique with contextual
implant placement, emphasizing the role of the blood clot, combined with collagen sponges, as a natural scaffold
and the osteogenic potential of the subantral membrane in guided bone regeneration, with reduced morbidity of
the patient.
Case presentation: To describe the surgical technique, the clinical case of a 38-year-old Caucasian woman with a
lateral posterior edentulism was selected. The rehabilitation was solved by a graftless sinus augmentation technique
with a contextual implant placement.
For each implant, a resonance frequency analysis evaluation was reported as implant stability quotient values. The
performance of the implant stability quotient values followed a gradual increase from time zero to the sixth month, as
the clot was differentiated into osteoid tissue and then into bone tissue, due to the scaffold effect conferred by the
equine collagen sponge. The stabilization phase took place between the fourth and the sixth month, according to the
implant stability quotient values.
Conclusions: Our graftless sinus augmentation technique seems to be very predictable thanks to the osteoconductive
principles on which it is based, and in association with the proper management of peri-implant soft tissue, so as to
increase the amount of keratinized tissue, which could represent the new gold standard for this type of rehabilitation
in the future.
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Maxillary sinus augmentation procedures’ background
Oral implantology in prosthetic rehabilitation is certainly
one of the most important acquisitions for dentistry in the
last sixty years.
Often, in the posterior region of maxilla, following the
loss of teeth, there is a reduction in volume of the bone
crest and this reduction is further exacerbated by increased
pneumatization of the maxillary sinuses. Therefore, the* Correspondence: r.marini@uniroma1.it
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unless otherwise stated.presence of a residual bone crest volumetrically unsuitable
for the insertion of endosseous implants has led to the def-
inition of surgical procedures designed to restore a suitable
bone volume for implant procedures.
The maxillary sinus augmentation procedure is currently
considered a highly predictable and safe technique that
allows the insertion of osseointegrated implants into the
atrophic posterior maxilla [1], where the pneumatiza-
tion of Higmoro’s antrum on one side and the edentu-
lous alveolar process resorption by another side, often
compete to make implant anchorage prosthetic rehabili-
tation impossible [2-7].l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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possibility of introducing blade implants into the maxillary
sinus, by partially lifting the Schneider membrane without
tearing it.
In 1975, Tatum proposed to raise the sinus membrane
by performing a modified Caldwell-Luc technique, then
called the ‘inverted lateral window’, introducing, as graft,
autologous bone taken from the rib [9].
The first publication of this technique is due to Boyne
and James [10], who in 1980 reported 14 cases of autolo-
gous graft (iliac crest) with simultaneous insertion of blade
implants. Branemark [11] in 1984 reported 139 penetrat-
ing implants into the maxillary sinus and nasal cavity with
a follow-up from two to ten years.
In 1986, Smiler and Holmes [12] proposed a technique
that involves the use of nonresorbable hydroxyapatite as
a bone graft substitute.
Several grafts are currently used: autologous, homolo-
gous, heterologous or alloplastic. Moy [13] and Smiler [14]
have published studies in which the different materials are
compared.
In 1987, Misch [15] proposed a maxillary atrophy
classification that also takes into account the therapeutic
solution, as well as the most recent classification proposed
by Favero and Branemark [16] in 1994: it takes into ac-
count the maxillary atrophy in its entirety.
There is currently no single protocol to follow when
planning this type of surgical operation: some variables
such as the crestal height, the separation between the
walls and the sinus pneumatization, the state of the
membrane or the type of residual bone in the crest, affect
the surgical indication and the techniques that must be
adopted.
Antroplastic techniques can be divided into: maxillary
sinus augmentation procedures (or lateral access sinus
lifts) and mini sinus lifts (or crestal access sinus lifts).
The first are those most frequently indicated in large-
volume bone regeneration, the second are indicated in
lower-volume regeneration, taking advantage of the prep-
aration of the implant site such as access to the maxillary
sinus.
The lateral access technique with insertion of vari-
ous types of graft has been well codified and showed
a good success predictability of the grafts and im-
plants inserted. In the last 30 years it has undergone
numerous changes, aimed at reducing the overall invasive
surgery, the intra- and postoperative complications, and
the patient’s morbidity.
The excessive opening of the side window, the
extraoral bone graft harvesting and the late implant
insertion made the surgical operation invasive and
expensive.
Initially, the surgical technique used for antrostomy
access made use of rotary instruments and the mostfrequent intraoperative complication was the perforation
of the sinus membrane, with percentages ranging between
20 and 30% for different authors [17,18].
Lately, oral surgeons have begun to use a piezoelectric
tool to perform the antrostomy and the percentage of
perforations has significantly decreased [19,20].
The crestal access, on the other hand, involves less sur-
gical invasiveness and has an equally predictable success
rate of endosseous implants.
The crestal approach sinus-lifting technique introduc-
tion has further increased the indications for contextual
implant placement and alveolar ridge increase. In these
cases, the technique requires dedicated instrumenta-
tion and remarkable operator sensitivity during the
lifting of the membrane to avoid tearing. In any case,
the indication to perform a crestal approach with simul-
taneous implant insertion appears to be limited to clinical
situations with residual alveolar ridge height >5mm and
where the requested vertical increase does not exceed
5mm [21,22].
In addition to the surgical techniques, the interest of
clinical research has focused particularly on the biomate-
rials used to perform the filling of the lifted maxillary
sinus [21], as the ability to generate bone in its interior
was attributed mainly to the biomaterials’ intrinsic char-
acteristics rather than the spontaneous healing capacity
of the area [23].
The biomaterials used nowadays can be divided into
autogenous (derived from the same patient), allogenic
(obtained from another human being), and xenogenic
(derived from another animal species).
Autologous bone is the gold standard for its recognized
inductive and conductive abilities and because of its in-
trinsic osteogenicity [24]. It, in fact, coming from the same
patient, guarantees the complete absence of adverse im-
mune response.
Mineralized or demineralized freeze-dried alloplastic
bone grafts (FDBA, DFDBA), xenografts of bovine origin,
sulphate and calcium phosphate, hydroxyapatite, and bio-
glass have been widely employed and scientifically evalu-
ated in order to determine the formation of new bone
within the maxillary sinus and to allow osseointegration of
the implants.
All substitutes possess the ability to form bone even if
there is a wide range of results from a histomorphometric
point of view [25-28].
Bone regeneration, in fact, follows valid principles
[29,30] independently of the type of graft used, accord-
ing to which there is the possibility of new bone forma-
tion whenever it shall create a space that can be
maintained, favoring growth factors input and avoiding
infectious phenomena.
In this report, a graftless sinus augmentation technique
with contextual implant placement is described: the use of
Chipaila et al. Journal of Medical Case Reports 2014, 8:437 Page 3 of 11
http://www.jmedicalcasereports.com/content/8/1/437a simple collagen sponge is able to stabilize the blood clot
in the early stages of healing.
Blood clot and Schneiderian membrane osteogenic
potential
The blood clot regenerative potential is currently a topic
of much discussion in the literature and it is the research
subject of many authors, both for its application in guided
bone regeneration (GBR) and for its application in graft-
less sinus augmentation techniques [6,7,31-33].
The blood clot revaluation, as the only filler in the
maxillary sinus augmentation technique in an era in
which the biological and synthetic biomaterials seem to
have taken over, is mainly due to Lundgren, who ob-
served, after a maxillary sinus cyst enucleation, that the
cavity left by the membrane elevation after the cyst re-
moval was filled with bone within three months without
doing anything.
In this context, he decided to further investigate this
phenomenon by developing a new surgical approach,
which consisted of the following steps: to carve the bone
window with a beveled incision and then to remove it
completely, to raise the Schneiderian membrane without
tearing it, to insert the implant fixtures and to relocate
the bone operculum, allowing the blood clot to fill the
free space between the sinusal membrane and basal
bone. The histological analysis confirms the perfectly
vital bone formation starting from the surface of the
antral membrane, so assuming its osteogenic potential
[31,34,35].
Lambert et al. in 2010 [36], compared, in a study on
rabbits, different materials to be used as fillers in the
function of subantral bone regeneration, including the
blood clot, autogenous bone and bovine hydroxyapatite
(BHA): all three space-fillers allowed bone formation.
The authors emphasized that the blood clot is an excel-
lent growth factor carrier, showing initially a faster and
greater bone formation, but the increase in volume is
significantly reduced at five weeks postoperatively, show-
ing that the blood clot alone may not be able to provide
an adequate resistance to the sinusal re-expansion.
These observations are in agreement with other authors
[37,38], who stress that the osteoinductive properties of
the blood clot alone would, therefore, be limited primarily
by the inability to maintain the created space.
In this context, in our report we have considered the
importance of maintaining blood clot stability through
the simultaneous insertion of the implant fixtures and
the association of the collagen sponge, in order to faci-
litate the membrane repositioning maintenance in the
long term.
The results, assessed clinically and radiographically,
confirmed the osteoinductive effects of the blood clot, and
did not find any limitations in relation to the difficulty ofmaintaining the created space, overcome by the strategy
of our surgical technique.
Various studies have also been conducted on the
Schneiderian membrane and on its osteogenic poten-
tial [32,33].
Srouji et al. [32] have demonstrated both in vitro and
in vivo that the antral membrane contains osteoprogeni-
tor cells able to proliferate and differentiate: the authors
have thereby provided a biological background for the
understanding of the clinical phenomenon observed in
the surgical procedure.
Histologically, the Schneider membrane is composed of
several layers: an epithelial lining, a richly vascularized lam-
ina propria, and a deeper layer that covers the jawbone.
This last layer is the interface with the underlying bone,
and could be compared to the periosteal structure [32].
In vitro, the osteoprogenitor cells in culture have been
brought to secrete alkaline phosphatase, BMP-2, osteo-
pontin, osteonectin, osteocalcin, and also to mineralize
their extracellular matrix, as already demonstrated by
Gruber et al. in 2004 [39] with cells of porcine sinus
mucosa. In vivo, the heterotopic implantation of mem-
brane cells combined with an osteoconductive scaffold
led to the formation of new trabecular bone.
In a subsequent report, Srouji et al. [33] through an
in vivo simulation of an animal model sinus lift, showed
the osteogenic potential of Schneider’s membrane and
its possible contribution to bone regeneration in sinus
lift procedures.
Palma et al. [34] in a study on primates, inserted
Brånemark implants both with a smooth and an oxidized
surface, with a contextual sinus lift with or without
autogenous bone application and analyzed the results at
six months by performing block sections, reporting these
conclusions:
1. the obtained bone augmentation amount was not
significantly different between the group with an
autogenous bone graft and the one without a graft;
2. the use of surface-treated implants improved the
bone-implant contact;
3. new bone was evident between the Schneiderian
membrane and the graftless implant sites,
demonstrating therefore, the osteoinductive
potential of the membrane.
These acquisitions bring further understanding to
intimate biological mechanisms that are the basis of
our study and confirm the trend to implement thera-
peutic strategies in which the body may be enabled to
express the greatest potential for healing with the
least possible external interference, increasing predict-
ability and decreasing the potentially negative external
variables.
Figure 2 Surgical procedure of sinus lift and implants placement.
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In this report, we present the implant-prosthetic rehabili-
tation of a maxillary posterior edentulism case (area 1.4 to
1.5) through a graftless sinus augmentation technique and
contextual implant fixtures placement. The purpose of the
study is to describe the surgical technique aimed at the
edentulous site implant rehabilitation, enhancing the role
of the blood clot as a biofiller between implant screw and
sinus membrane, and stressing the Schneiderian mem-
brane osteogenic potential.
Case presentation
Our patient (a Caucasian woman, aged 38), with no his-
tory of previous or current diseases, presented with a
maxillary lateral edentulism in the area 1.4 to 1.5. The pre-
liminary radiographic evaluation showed bone dimensions
of about 6 to 8mm in the coronoapical direction and 4 to
6mm in the bucco-oral direction (Figure 1).
After the preliminary evaluation, the operation plan-
ning started. The rehabilitation of this maxillary edentu-
lism was solved through the placement of two implant
fixtures with the contextual sinus augmentation procedure
(Figures 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 and 14). The sur-
gical operation was performed under local anesthesia,
using mepivacaine (20mg/ml) with adrenaline (1:100,000),
using the truncal technique at the infraorbital foramen
and major palatine foramen. On the buccal side, a full-
thickness paramarginal trapezial flap extended from elem-
ent 1.3 to element 1.7 was performed. Subsequently, a
lateral bony window with a Beaver 65 blade used as a
surgical scalpel was made.
The bone segment was removed by anatomical twee-
zers and stored in sterile physiological solution at 4°C.
The sinusal membrane was detached by special retractors
and raised so as to achieve a curtain effect. An equine
collagen sponge was placed in the antral area between the
sinus floor and the raised membrane, to protect the latterFigure 1 Preoperative orthopanoramic X-ray.under the Prichard’s vane ending, during the surgical
alveoli preparation.
The neo-alveoli for the implant fixtures placement were
performed through the crestal area, with the implant
kit drills.
The two implants, with a diameter of respectively 3.5mm
(normal platform, NP) and 4.3mm (regular platform, RP), a
length of 13mm and conical connection characteristics
were placed in situ. The primary stability was measured by
resonance frequency analysis (RFA).
The apical area of the fixtures was soaked by the blood
clot, in association with an equine collagen sponge, in
the sinus area between the sinus floor and the raised
membrane. The bone segment mobilized to perform the
bone window was repositioned, the surgical area was cov-
ered with a collagen sponge layer and the flap was sutured
with a nonabsorbable polyfilament.
After monitoring our patient for half an hour, no
hemorrhage signs or local and/or general suffering was
observed, so she was discharged with a prescription for
antibiotic therapy (amoxicillin + clavulanic acid cpr. 1g
for oral administration every 12 h for six days), anti-
inflammatory (sodium naproxen cpr. 275mg for oralFigure 3 Surgical procedure of sinus lift and implants placement.
Figure 4 Surgical procedure of sinus lift and implants placement. Figure 6 Surgical procedure of sinus lift and implants placement.
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tic therapy (0.2% chlorhexidine + cetilpiridine chloride).
Recommendations for oral hygiene and feeding tech-
niques were supplied with the aim of optimizing the post-
operative course.
The suture removal on the seventh day showed a good
healing of tissues, with a modest share of keratinized
tissue differentiation.
The radiographic postoperative control at six months
showed a conspicuous neo-bone apposition around the
apical area of the implant fixture (Figure 15), in agree-
ment with the indications of Lioubavina-Hack et al. [40],
according to whom the osteo-implant unit can be consid-
ered fully functional when, at X-ray examination, there is
an increase in radiopacity surrounding the implant with
progressive and gradual decreasing to the periphery.
With regard to the condition of the soft tissues, heal-
ing took place by first intention, with net retention of
keratinized tissue (Figure 16).
To establish the implant survival Albrektsson [41]
proposed the following criteria:
1. the system immobility;
2. the absence of peri-implant radiolucency;Figure 5 Surgical procedure of sinus lift and implants placement.3. the absence of persistent inflammation signs or
symptoms.
To clinically evaluate the implant stability and osseoin-
tegration, we adopted resonance frequency analysis (RFA),
a noninvasive diagnostic technique used to determine the
ability of an implant to be subjected to load.
RFA is, in fact, the only noninvasive method that can
guide the selection of prosthetic times. Adequate implant
stability in bone is crucial to allow, after the insertion of
an implant, undisturbed healing with new bone formation.
The implant stability is divided into primary and
secondary:
– the primary stability is a mechanical parameter that
depends on the bone quantity and quality, the
system geometry and the adopted technique [42].
– the secondary stability can be considered as the
stability increase as a result of the implant
placement during the healing.
This increase is attributable to the bone formation and
the remodeling process that occurs in the tissue-implant
interface in the surrounding area.Figure 7 Surgical procedure of sinus lift and implants placement.
Figure 8 Surgical procedure of sinus lift and implants placement. Figure 10 Surgical procedure of sinus lift and implants placement.
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implant stability quotient (ISQ) values. Measurements
were performed by an ISQ device (Osstell ISQ, Osstell
AB, Gothenburg, Sweden).
Both implants have shown sufficient primary stability
associated with mean values of ISQ=54.22.
At the end of the second month, a higher stability than
the threshold value of 57 ISQ was recorded in both
implants, with an average value of 59.8 ISQ.
A gradual increase in ISQ values was observed until
the third and fourth month, reaching an average value of
63.2 ISQ, after which the ISQ values appeared to level off
in a straight line.
The gradual filling of the defect is, therefore, accom-
panied by an increase in the ISQ values (Table 1).
The ISQ average values trend found in our study
(Figure 17) does not seem to be very different from that
described in the literature [43] in reports that consider
different clinical situations and graft applications, sug-
gesting that the graft incorporation plays a marginal role
on implant stability.
On the basis of the recorded values, we can state that
the stabilization phase took place between the fourth
and sixth month.Figure 9 Surgical procedure of sinus lift and implants placement.Discussion
Nowadays, blood clot bone regeneration potential is in-
creasingly corroborated by the literature [6,44]. The pre-
sent report wants to underline how the blood clot, rich in
autogenous growth factors, can act as a natural scaffold
between the guide walls of the antral floor, implant screw
and raised Schneiderian membrane and differentiate itself
into bone-osteoid tissue, providing secondary stability, a
necessary condition for osseointegration.
In our study, the Schneiderian membrane lifting
created the conditions to allow the filling of the space
delimited by its detachment with the stable clot (capable
of turning into bone tissue). The space was procured and
maintained by the implant placement while the use of a
simple equine collagen sponge allowed the clot stabiliza-
tion in the early stages of healing.
In relation to the results obtained in our study and the
related literature, we can state that the grafting materials
currently used as subantral space fillers seem to have a
more mechanical function that is not purely biological,
and this may explain why, in terms of volumetric stability,
slow resorption grafts are more effective than autogenous
bone [36].Figure 11 Surgical procedure of sinus lift and implants placement.
Figure 12 Surgical procedure of sinus lift and implants placement. Figure 14 Surgical procedure of sinus lift and implants placement.
Chipaila et al. Journal of Medical Case Reports 2014, 8:437 Page 7 of 11
http://www.jmedicalcasereports.com/content/8/1/437The graftless sinus augmentation technique with con-
textual implants placement is widely supported by the
clinical experience of various authors and also by experi-
mental studies [44,45].
Srouji et al. in 2009 [32], showed how the basal cell layer
of Schneider’s membrane has a behavior associated to that
of the periosteum, able to produce the osteoprogenitor
cells and humoral factors necessary for bone regeneration
(BMP2, osteonectin, osteocalcin and osteopontin), requir-
ing only the presence of a stable blood clot.
Lundgren in his report [6], pointed out that the bone
deposition, despite the continuous bone remodeling, is
the net result of the sinus mucosa elevation in the maxil-
lary sinus augmentation without graft application, while
in sites where the technique consisted of bone graft ap-
plication, a situation of bone resorption predominates.
At the end of this article, the author concludes that the
simple elevation of the sinus membrane and the simul-
taneous implant placement resulted in bone formation
and osseointegration of implant fixtures.
Many other authors have subsequently observed bone
formation after the sinus lift without the use of bone
grafts [6,31,46-48].Figure 13 Surgical procedure of sinus lift and implants placement.In the context of guided tissue regeneration, various
authors have firmly established the importance of blood
clot, with its endogenous growth factors, in allowing
bone tissue formation [6,46,49-54].
The osteogenesis process always starts with the bone
defect neovascularization, which is an indispensable con-
dition of every osteogenetic event.Figure 15 Radiographic postoperative control at six months.
Figure 16 Clinical aspect of the soft tissue at six months.
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mesenchymal cells with osteogenic potential capacity,
the bone regeneration depends on the influence of the
systematically and locally produced bone, by inductor
factors such as growth factors and hormones, and by the
formation of an appropriate scaffold for the proliferation
and differentiation of osteoprogenitor cells.
The first stage is realized during the first four to six
weeks.
It is characterized by the formation of a clot and the
vascular structures migration by the marrow spaces of
the walls that surround the defect, in the space below
the membrane, which is followed by the beginning of
the osteoid tissue deposition. This tissue is also defined
primary spongy tissue and is constituted by bone with
interwoven fibers that, advancing, delimit and surround
the newly formed vessels, and, merging between them,
define the neoformed intertrabecular spaces.
The central part of the defect, not yet filled with regen-
erated tissue, is composed of loose connective tissue with
collagen fibers without orientation, fibroblasts, macro-
phages, and vases.
The second stage occurs in the subsequent two to
three months, during which the maturation of the
cancellous bone advances and the formation of cortical
bone begins.
The osteoid bone (primary cancellous bone) undergoes
mineralization by osteoblast input and at its periphery a
new cortical bone, consisting of parallel bundles of
lamellar bone, begins the differentiaton.
The lamellar bone is deposited more slowly than the
osteoid bone, which has rapidly filled the empty spacesTable 1 Mean implant stability quotient values of the two fix




ISQ time 0 ISQ 2 m
1.4 3.5 - 13 Good 54 58
1.5 4.3 - 13 Good 56 61
ISQ, implant stability quotient.in the first phase, and needs a stable surface on which
the collagen fibrils can be deposited in parallel fibers.
The intertrabecular spaces are gradually reduced in
volume up to the size of the Haversian canals and, with
the neighboring concentric lamellae, they form the primary
osteons.
The last phase, which is achieved after three to four
months, is characterized by the cortical bone maturation
and by the cortical and medullary bone remodeling, a
phase that can continue even longer.
In this phase, various osteoclasts invade the remodel-
ing area to eliminate the fibrous bone while the neo-
osteoblasts deposit layers of mature lamellar bone that
leads to a thinning of the connective tissue.
In the ‘ex novo’ bone tissue formation the platelets
play a key role during the first phase of the healing
process, when there is an initial deposit of fibrin and the
formation of blood clot.
This phase is characterized by a significant activation
of chemical signals mediated by cytokines and growth
factors.
In fact, the posthemorrhagic clot formation process,
through platelet aggregation and cell lysis, causes the
release of coagulation cascade factors and growth factors,
such as platelet-derived growth factor (PDGF), insulin-like
growth factors (IGF 1, IGF 2) and vascular endothelial
growth factor (VEGF) that are known for their activating
effect on osteoblasts and osteoclasts, and transforming
growth factor beta (TGF-β), which initiate the formation
of bone tissue.
The osteoblastic precursors are responsible, after differ-
entiation into osteoblasts, for the second phase of the
healing process (enchondral and/or intramembranous
ossification) through the synthesis of collagen and other
extracellular matrix components.
A substrate or carrier suitable for the osteoinductive
signal is also needed to support and guide the new bone
formation. Sampath and Reddi [55] in 1984 have shown
that the type I cross-linked collagen is the most appro-
priate carrier to promote the activity of the osteoinductive
signal.
The collagen is needed in the processes of tissue repair
for its osteoblastic and angiogenic activity, and also for
its hemostatic and debridement properties. The collagen
bound to fibronectin promotes the anchoring of mesen-
chymal stem cells progenitors, which exerts its chemo-
tactic action and allows differentiation into osteoblasts.tures from time zero to six months
onths ISQ 3 months ISQ 4 months ISQ 5 months ISQ 6 months
61 63 65 65
62 63 64 64
Figure 17 Performance of implant stability quotient values in
the two sites from time zero to six months. The units of the
vertical axis are ISQ (implant stability quotient) values. The unit of
the horizontal axis is the time expressed in months (from time 0 to
the 6th month).
Chipaila et al. Journal of Medical Case Reports 2014, 8:437 Page 9 of 11
http://www.jmedicalcasereports.com/content/8/1/437Vice versa, through the recruitment of monocytes/
macrophages, both osteoblast activity and the angiogen-
esis process are stimulated at the healing site.
The hemostatic action is exerted as the collagen is able
to activate the platelet membrane receptors, responsible
for their aggregation and the lysis process. During the
first week, the collagen is able to strengthen the fibrin
action in the primary clot formation while in the second
week it replaces the function of fibrin.
Collagen, also carrying out chemotactic monocytes/
macrophages cell lines, promotes the formation of osteo-
clasts which, through their action in bone resorption,
can attract, activate, and collaborate with osteoblasts in
bone arrangement and remodeling.
The collagen sponge used in our clinical case offered,
therefore, the natural substrate for proper regeneration
of bone tissue, facilitating and promoting the physio-
logical process of regeneration. Therefore the space con-
taining the blood clot was created and maintained. This
condition allowed the bone regeneration, through the
formation of a healing pattern that provided for the
migration of cells with an angiogenic and osteogenic
potential from the medullary spaces of the adjacent
bone tissue to the surgical site. The formation of an
angiogenic front and the differentiation of perivascular
cells into osteoblasts led to the deposition of extracellular
matrix (substantially connective tissue) that was subse-
quently mineralized in osteoid/bone-like tissue.
The limitations of this technique are represented by
clinical situations in which there is not sufficient bone
volume in order to ensure the primary stability of the
implant fixtures (crestal height <5 to 6mm), and in
such cases, it is preferable to insert autologous grafts
as fillers instead of synthetic biomaterials, as autologous
bone is the gold standard, because it is rich in cytokines,growth factors, and so on, like the blood clot, with the
advantage of ensuring an excellent scaffold graft in these
circumstances.
On the other hand, the advantages of this technique
are: a lower morbidity for the patient, because there is
no involvement of a donor site, the lower cost of the
procedure, because there is no bone substitutes or mem-
brane application, and the same timing of prosthetic fi-
nalization when compared to the techniques that involve
the use of bone substitutes.Conclusions
Good patient compliance and the motivation for thorough
oral hygiene at home has led to an excellent postoperative
course. The clinical and radiographic follow-up at 0, 4 and
6 months and the excellent integration of the implant
system in the osteo-mucosal context, allowed by proper
soft tissue management, has consolidated the success of
the surgical technique, inter alia with wide confirmation
in the literature.
The application of growth factors in grafting biomate-
rials in order to improve the osteoinductive characteristics
increasingly pushes clinicians and researchers to reevalu-
ate the quality of the blood clot, pabulum rich in cytokines
and bone morphogenetic proteins, autogenous and able
to promote the differentiation bone, with significant
biological advantages.
Our radiographic controls showed a continuous and sig-
nificant peri-implant bone remodeling over time becom-
ing more and more homogeneous.
The results obtained from our study are encouraging
and comparable to those achieved with maxillary sinus
elevation techniques with biomaterial application.
Our results, therefore, in agreement with those reported
in the international literature, allow us to define the graft-
less sinus augmentation technique as a reliable and pre-
dictable surgical method.Consent
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